Purchase Order 12561518P0078
Award Date 5/17/18
Potential Completion Date 5/23/18
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Somerset, Franklin Township, NJ 08873, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Celltein LLC, operating as Lifetein, was awarded a $5,880 firm fixed-price purchase order by a civilian federal agency on July 2, 2019, for monoclonal antibody services with an ultimate completion date of November 1, 2019. The contract was not designated as a set-aside award and will be performed in Hillsborough Township, New Jersey. Celltein LLC specializes in custom peptide synthesis and related biological services, leveraging its expertise to provide monoclonal antibody development and...
- This federal contract award was issued by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Celltein LLC, doing business as Lifetein, a minority-owned, woman-owned small business that provides custom peptide synthesis, recombinant protein expression and purification, and other scientific services. The $18,200.00 firm fixed price contract does not have a set-aside designation. Celltein LLC has received previous contract awards from...
- The U.S. government awarded a purchase order contract to Biomatik USA, LLC for peptide synthesis services under Quote #SP5061729X12. This firm fixed price contract, awarded on August 11, 2015, carries a ceiling value of $4,350.40 and was completed by September 11, 2016. The contract was funded by a civilian agency within the Southeast Area and performed at Biomatik's facility located in Ottawa, Ontario, Canada. No set-aside designation was applied to this award. Biomatik USA, LLC is a biotech...
- The U.S. government awarded a $5,770 firm fixed price purchase order to Vivitide LLC (doing business as New England Peptide) on May 31, 2016, for the delivery of 3X affinity purified antibody packages including Oncorhyncin II, Beta Defensin, and Hepcidin, with dry ice included for shipment. The contract was completed on June 2, 2016, and performance took place in Gardner, Massachusetts. This was a civilian acquisition with no small business set-aside designation. Vivitide LLC is a specialized...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,913.20 firm fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for a custom peptide service. The contract has no set-aside designation and is set to be completed by June 14, 2024. Life Technologies is a provider of scientific instruments, reagents, and consumables that supports biomedical research and other applied...
- This federal contract award to Life Technologies Corporation, a division of Thermo Fisher Scientific, is for the purchase of custom peptides valued at $6,036.80. The contract, awarded by the Northeast Area civilian agency, has a completion date of April 2, 2018. It is a firm fixed-price purchase order and does not utilize any set-aside designations. Life Technologies Corporation has a history of providing scientific instruments, reagents, and services to support various federal initiatives...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...
- This $5,880.00 firm fixed price purchase order was awarded by the U.S. government to Biopeptide Co., Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation, for the custom synthesis of 25 milligrams of a BCL11A-dimethyl peptide sequence with 95% purity. The contract, which has no set-aside designation, was awarded on March 19, 2009 with a final completion date of April 12, 2009. The place of performance is San Diego, California. No additional context about the...
- The federal contract award AG7D28P150032 was issued by the Plains Area division of the U.S. Department of Health and Human Services to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The $9,758.50 firm fixed price purchase order is for the delivery of PEPSTAR PEPTIDE MICROARRAY PEPTIDES and does not have a set-aside designation. JPT Peptide Technologies has previously received over $250,000 in federal contract awards from...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for custom peptide synthesis on September 13, 2018, with a ceiling value of $17,503.39.</p> <p>Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of October 31, 2018. No set-aside category applies.</p>